Publications Office of the EU
REQUEST FOR INFORMATION: Reagents for PCR (16S gene multiplication) for examination of clinical patient samples - EU tenders
DisplayCustomHeader
Procurement Detail Actions Portlet
OP Portal - Procurement - Details

This page contains content generated automatically to improve findability and accessibility

- indicates text translated automatically in your browsing language

REQUEST FOR INFORMATION: Reagents for PCR (16S gene multiplication) for examination of clinical patient samples Text automatically translated in your browsing language Automatically translated

  • Announced
    20/06/2024
  • Estimated published
    31/08/2024
  • Today
    20/03/2025
Status
Announced
Type of contract
Supplies
Subject for Renewal
No
Buyer
HUS-yhtymä
Place of performance
NUTS code: Multiple place of performance
Location of buyer
NUTS code: FI1B1 Helsinki-Uusimaa
Business sector (Main CPV)
33696500 Laboratory reagents
Total estimated contract value (excluding VAT)
Not available
Total final contract value (excluding VAT)
Not available
Tender reference number
HUS 115-2024
Description

NOTE! This notice is not a contract notice or a call for tenders, and its publication does not trigger a call for tenders, but a request for information relating to a pre-study and market prospection. This document does not oblige the contracting entity to carry out the actual procurement. Replies to a request for information shall in no way bind the respondent in relation to any subsequent acquisition. Decisions to initiate a potential procurement process will be made after the market prospection. The HUS Group (hereinafter also referred to as the "Procurement Unit") is planning the competitive tendering of reagents for the general bacteria PCR (16S gene multiplication) to study clinical patient samples. The object of the procurement is the reagents needed for the multiplication of the 16S gene from clinical samples. The primers are designed by the client himself. The Customer shall provide the Supplier with information on the base order of the prime sequences. The reagents also include other PCR reagents (polymerase, buffer, NTP, water) suitable for primers, all of which must be bacterial DNA-free. If you have the opportunity to produce for HUS and are interested in participating in a possible tender, we ask you to respond to this market prospection. INSTRUCTIONS: In your reply, please provide the information requested below 1) Does your company have the possibility to produce custom primers for the Customer's use? 2) Please attach a product brochure or other description of the service and the pricing you use for custom primers. 3) Are the products in your assortment CE-IVD marked according to IVDR regulation. 4) Contact person and e-mail address related to possible market dialogue. - Please send your reply to: kilpailutus.laboratorio@hus.fi - Send your answers as soon as possible, but no later than 5 July 2024 at 12 noon. - Headline your reply "Response to request for information HUS 115-2024 General Bacterial PCR". Text automatically translated in your browsing language Automatically translated

Submission Method
Not available
Tenders may be submitted
Not available
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
The procurement involves the establishment of a framework agreement
Conditions for opening tenders (date)
Not available
Award method
Not available
Estimated value
Not available
Final contracted value
Not available
Award of contract
Not available
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.